Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Poland

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Allergy and Asthma Proceedings|August 14, 2009
Assessment of the association between pediatric asthma and Streptococcus pyogenes upper respiratory infectionDiana Frey, Robert Jacobson, Gregory Poland, et al.
The Journal of Allergy and Clinical Immunology|September 3, 2004
Latex allergens are not detectable in reconstituted smallpox vaccine or vaccine vial stoppersGregory Poland, Inna G Ovsyannikova, Richard T Jones, et al.
Vaccine|August 26, 2018
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forwardSusanna Esposito, Nicola Principi, Giovanni Rezza, et al.
The International Journal of Biostatistics|July 31, 2013
Assessing agreement of repeated binary measurements with an application to the CDC's anthrax vaccine clinical trialYi Pan, Charles E Rose, Michael Haber, et al.
Nucleic Acids Research|May 23, 2019
ImmuneRegulation: a web-based tool for identifying human immune regulatory elementsSelim Kalayci, Myvizhi Esai Selvan, Irene Ramos, et al.
Vaccine|January 18, 2007
Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of ageStephen K Tyring, Francisco Diaz-Mitoma, Larry G Padget, et al.
The Journal of Infectious Diseases|February 2, 2011
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variantRobert B Belshe, Sharon E Frey, Irene Graham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2008
Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological BoardJohn Neff, John Modlin, Guthrie S Birkhead, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2008
A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004Louisa E Chapman, John K Iskander, Robert T Chen, et al.
Vaccine|December 14, 2011
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of ageJoost N Vermeulen, Joep M A Lange, Stephen K Tyring, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Allergy and Asthma Proceedings|August 14, 2009
Assessment of the association between pediatric asthma and Streptococcus pyogenes upper respiratory infectionDiana Frey, Robert Jacobson, Gregory Poland, et al.
The Journal of Allergy and Clinical Immunology|September 3, 2004
Latex allergens are not detectable in reconstituted smallpox vaccine or vaccine vial stoppersGregory Poland, Inna G Ovsyannikova, Richard T Jones, et al.
Vaccine|August 26, 2018
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forwardSusanna Esposito, Nicola Principi, Giovanni Rezza, et al.
The International Journal of Biostatistics|July 31, 2013
Assessing agreement of repeated binary measurements with an application to the CDC's anthrax vaccine clinical trialYi Pan, Charles E Rose, Michael Haber, et al.
Nucleic Acids Research|May 23, 2019
ImmuneRegulation: a web-based tool for identifying human immune regulatory elementsSelim Kalayci, Myvizhi Esai Selvan, Irene Ramos, et al.
Vaccine|January 18, 2007
Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of ageStephen K Tyring, Francisco Diaz-Mitoma, Larry G Padget, et al.
The Journal of Infectious Diseases|February 2, 2011
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variantRobert B Belshe, Sharon E Frey, Irene Graham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2008
Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological BoardJohn Neff, John Modlin, Guthrie S Birkhead, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2008
A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004Louisa E Chapman, John K Iskander, Robert T Chen, et al.
Vaccine|December 14, 2011
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of ageJoost N Vermeulen, Joep M A Lange, Stephen K Tyring, et al.
Pageof 2